Target intelligence / Profile preview

Epiplakin (EPPK1)

Target
EPPK1
Molecular classification
Other (Plakin family protein, cytoskeletal linker)
01

Overview

Epiplakin is a large cytoskeletal linker protein encoded by the EPPK1 gene, notable for its unique structure composed entirely of plakin repeat domains and for containing the entire coding region within a single exon[1][3][4]. It belongs to the plakin family, whose members connect intermediate filaments (such as keratins) and support stress resistance in tissues[2][4]. Epiplakin is primarily found in epithelial tissues, including the skin and cornea. It binds to keratin intermediate filaments, influencing their organization and stability in response to stress and injury, and plays a protective role by regulating keratin filament reorganization and protecting epithelial tissue architecture during wound healing and cellular stress[2][3][7]. Epiplakin has been identified as an autoantigen in paraneoplastic pemphigus, a rare autoimmune blistering skin disorder, suggesting it may serve as a biomarker in some disease contexts[1][3]. No known drugs currently target epiplakin, and it is not regarded as a direct therapeutic target such as a receptor or enzyme[3][7][8].

Other names
EpiplakinEPPK1EPIPLEPIPL1450 kDa epidermal antigenepidermal autoantigen 450K
02

Biological functions

Cytoskeletal organizationIntermediate filament bindingMaintenance of epithelial tissue integrityRegulation of keratinocyte migration and proliferationResponse to cellular/mechanical stress
03

Disease associations

Skin autoimmune disease (as autoantigen)Melanotic medulloblastomaParaneoplastic pemphigusPotential modifier in wound healing
04

Biomarkers

Epidermal autoantigen in certain autoimmune skin diseases

Beyond the preview

Go deeper on Epiplakin (EPPK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epiplakin (EPPK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call